← Leaderboards
Marc Michael Baum
Oak Crest Institute Of Science
$19,823,975
Attributed
$21,683,993
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,094,858 · 9
CDC$0 · 1
By mechanism
U19$22,597,304 · 3
R01$17,497,554 · 7
Top collaborators
- Samuel Lai5 shared
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsPharmaceutical PreparationsIn VivoLeadAnti-Retroviral AgentsPreventionVaginaAids PreventionPreventDoseSafetyOralDrug Delivery SystemsRegimenDrug KineticsSheepResponseInnovationIn VitroMacacaFutureDesignHiv InfectionsSuccess
Grant awards (43)
A Novel, Multi-compartment Intravaginal Ring for Prevention of Genital Herpes and Unintended Pregnancy$828,713
R01 · FY2025 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$726,042
R01 · FY2025 · AI · contact PI
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention$725,974
R01 · FY2025 · AI · contact PI
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention$67,212
R01 · FY2025 · AI · contact PI
A Novel, Multi-compartment Intravaginal Ring for Prevention of Genital Herpes and Unintended Pregnancy$841,397
R01 · FY2024 · AI · contact PI
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention$745,037
R01 · FY2024 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$736,698
R01 · FY2024 · AI · contact PI
Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception$728,629
R01 · FY2024 · HD · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$765,964
R01 · FY2023 · AI · contact PI
Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception$746,693
R01 · FY2023 · HD · contact PI
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention$725,049
R01 · FY2023 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$1,302,826
R01 · FY2022 · AI · contact PI
Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception$740,660
R01 · FY2022 · HD · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$781,994
R01 · FY2021 · AI · contact PI
Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception$744,855
R01 · FY2021 · HD · contact PI
Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception$759,199
R01 · FY2020 · HD · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$838,173
R01 · FY2019 · AI · contact PI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,716,710
U19 · FY2018 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$838,140
R01 · FY2018 · AI · contact PI
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings$568,173
U19 · FY2018 · AI · contact PI
Core A: Administrative & Regulatory$326,460
U19 · FY2018 · AI · contact PI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,651,503
U19 · FY2017 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$835,245
R01 · FY2017 · AI · contact PI
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings$626,643
U19 · FY2017 · AI · contact PI
Core A: Administrative & Regulatory$160,588
U19 · FY2017 · AI · contact PI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$4,434,672
U19 · FY2016 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$812,903
R01 · FY2016 · AI · contact PI
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings$619,915
U19 · FY2016 · AI · contact PI
Core A: Administrative & Regulatory$162,676
U19 · FY2016 · AI · contact PI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,333,050
U19 · FY2015 · AI · contact PI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$867,958
R01 · FY2015 · AI · contact PI
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings$624,650
U19 · FY2015 · AI · contact PI
Core A: Administrative & Regulatory$181,345
U19 · FY2015 · AI · contact PI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,274,930
U19 · FY2014 · AI · contact PI
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings$727,419
U19 · FY2014 · AI · contact PI
Ex Vivo Model for Assessing the Vaginal Disposition of PrEP Antiretrovirals$456,536
R01 · FY2014 · AI · contact PI
Core A: Administrative & Regulatory$188,570
U19 · FY2014 · AI · contact PI
Ex Vivo Model for Assessing the Vaginal Disposition of PrEP Antiretrovirals$440,979
R01 · FY2013 · AI · contact PI
Ex Vivo Model for Assessing the Vaginal Disposition of PrEP Antiretrovirals$440,678
R01 · FY2012 · AI · contact PI
Real-time in Situ Aerosol Monitoring in Mine Atmospheres$0
R01 · FY2005 · OH
Real-time in Situ Aerosol Monitoring in Mine Atmospheres$0
R01 · FY2004 · OH
Real-time in Situ Aerosol Monitoring in Mine Atmospheres$0
R01 · FY2003 · OH
Real-time in Situ Aerosol Monitoring in Mine Atmospheres$0
R01 · FY2002 · OH